FDA recall D-0750-2021

Product

Tizanidine HCl Tablets, USP 4 mg, 150-count bottles, Rx only, Mfd By: Dr. Reddy's Laboratories limited, Srikakulam District, 532 409 INDIA, NDC 55111-180-15.

Reason for recall

Failed Tablet/Capsule Specification: Some tablets are shaved

Distribution

Nationwide within the United States

Key facts

Status

Terminated

Initiation date

2021-07-19

Report date

2021-08-25

Termination date

2022-12-21

Voluntary/Mandated

Voluntary: Firm initiated

Location

Princeton, NJ, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0750-2021